Programmed cell death ligand 1 expression in esophageal squamous cell carcinoma: a comparative analysis of three different assays

被引:0
|
作者
Lei Guo
Ying Ji
Wei Guo
Peng Song
Xue-Min Xue
Guang-Yu Bai
Bin Qiu
Jian-Ming Ying
Shu-Geng Gao
机构
[1] Beijing 100020
[2] Beijing 100021
[3] Beijing Chao-Yang Hospital
[4] Capital Medical University
[5] ChinaDepartment of Pathology
[6] ChinaDepartment of Thoracic Surgery
[7] Chinese Academy of Medical Sciences and Peking Union Medical College
[8] Department of Pathology
[9] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
关键词
D O I
暂无
中图分类号
R735.1 [食管肿瘤];
学科分类号
摘要
As one of the most aggressive and lethal malignant tumors, the 5-year survival rate of oesophageal cancer is less than 20%.[1] There are two main pathological subtypes of esophageal cancer: esophageal
引用
收藏
页码:2890 / 2892
页数:3
相关论文
共 50 条
  • [1] Programmed cell death ligand 1 expression in esophageal squamous cell carcinoma: a comparative analysis of three different assays
    Guo, Lei
    Ji, Ying
    Guo, Wei
    Song, Peng
    Xue, Xue-Min
    Bai, Guang-Yu
    Qiu, Bin
    Ying, Jian-Ming
    Gao, Shu-Geng
    CHINESE MEDICAL JOURNAL, 2021, 134 (23) : 2890 - 2892
  • [2] Comparative analysis of programmed cell death ligand 1 assays in renal cell carcinoma
    Lee, Kyu Sang
    Choe, Gheeyoung
    Yun, Sumi
    Lee, Kyoungyul
    Moon, Seyoung
    Lee, Sangchul
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    HISTOPATHOLOGY, 2020, 77 (01) : 67 - 78
  • [3] Clinical Significance of Programmed Death Ligand-1 Expression in Esophageal Squamous Cell Carcinoma
    Ito, Nozomi
    Tsujimoto, Hironori
    Horiguchi, Hiroyuki
    Shimazaki, Hideyuki
    Miyazaki, Hiromi
    Saitoh, Daizoh
    Kishi, Yoji
    Ueno, Hideki
    JOURNAL OF SURGICAL RESEARCH, 2020, 251 : 321 - 328
  • [4] Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
    Chen, Kaiyan
    Cheng, Guoping
    Zhang, Fanrong
    Zhang, Nan
    Li, Dan
    Jin, Jiaoyue
    Wu, Junzhou
    Ying, Lisha
    Mao, Weimin
    Su, Dan
    ONCOTARGET, 2016, 7 (21) : 30772 - 30780
  • [5] Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
    Ryul Kim
    Bhumsuk Keam
    Dohee Kwon
    Chan-Young Ock
    Miso Kim
    Tae Min Kim
    Hak Jae Kim
    Yoon Kyung Jeon
    In Kyu Park
    Chang Hyun Kang
    Dong-Wan Kim
    Young Tae Kim
    Dae Seog Heo
    World Journal of Gastroenterology, 2016, 22 (37) : 8389 - 8397
  • [6] Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
    Kim, Ryul
    Keam, Bhumsuk
    Kwon, Dohee
    Ock, Chan-Young
    Kim, Miso
    Kim, Tae Min
    Kim, Hak Jae
    Jeon, Yoon Kyung
    Park, In Kyu
    Kang, Chang Hyun
    Kim, Dong-Wan
    Kim, Young Tae
    Heo, Dae Seog
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8389 - 8397
  • [7] Comparative analysis of programmed cell death ligand 1 (PD-L1) assays in renal cell carcinoma
    Shim, B.
    Lee, K. S.
    Yun, S.
    Lee, K.
    Moon, S.
    Choe, G.
    VIRCHOWS ARCHIV, 2019, 475 : S185 - S185
  • [8] Programmed cell death 1 expression in esophageal squamous cell carcinoma and association with clinical characteristics
    Feng, Z.
    Li, Xiang-lei
    Hai-tao, W.
    Zuo-pei, W.
    Bao-li, H.
    Hai-feng, Z.
    Xiao-long, W.
    Li, L.
    INDIAN JOURNAL OF CANCER, 2015, 52 (07) : 176 - 178
  • [9] The prognostic significance of programmed cell death-ligand 1 expression in pulmonary squamous cell carcinoma
    Hung, Jung-Jyh
    Wu, Yu-Chung
    Hsu, Wen-Hu
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [10] Contrasting Roles of Programmed Death-Ligand 1 Expression in Tumor and Stroma in Prognosis of Esophageal Squamous Cell Carcinoma
    Murakami, Tomohiro
    Booka, Eisuke
    Furuhashi, Satoru
    Sakai, Yuki
    Sekimori, Kenichi
    Haneda, Ryoma
    Fujihiro, Mayu
    Matsumoto, Tomohiro
    Morita, Yoshifumi
    Kikuchi, Hirotoshi
    Hiramatsu, Yoshihiro
    Baba, Satoshi
    Takeuchi, Hiroya
    CANCERS, 2024, 16 (06)